July 13, 2026 By Pranay Parikh, MD

Should we hire a healthcare growth agency or build in-house?

The U.S. Bureau of Labor Statistics puts the national median marketing-manager wage at $161,030, before benefits, payroll tax, recruiting, software, or specialist support. Hire an agency when the bottleneck is scarce expertise and you already have an internal owner, approved claims process, usable measurement, and repeatable offer. Build in-house when the work is continuous and company knowledge changes the daily decisions; use a hybrid when strategy, clinical boundaries, data, and economics must stay inside but specialist execution does not need to be permanent.

The bottleneck decides the team

“Agency or in-house?” sounds like a cost question. It is usually an operating-model question: where is the missing judgment, how often is it needed, and who must own the decision after the campaign launches?

An agency is useful when you need a capability faster than you can recruit and develop it. That may be senior paid-media judgment, creative testing, conversion work, or a repair to measurement and reporting. A specialist team can bring several disciplines to a narrow problem without asking you to create a permanent role for each one. The tradeoff is distance. An agency will rarely absorb clinical nuance, product changes, patient feedback, or internal politics as naturally as someone sitting inside the company. It also cannot compensate for slow approvals, an unproven offer, unclear economics, or a founder who has not assigned an accountable owner.

An in-house team is stronger when the work is recurring, the strategy is repeatable, and daily context changes the quality of the decision. Internal operators can hear what clinicians and support teams are seeing, connect campaign feedback to the intake experience, and preserve learning between launches. The tradeoff is fixed cost and management load: recruiting time, salary and benefits, software, specialist coverage, supervision, and the risk of hiring one generalist for a job that quietly contains five specialties. A senior hire is especially expensive when the company has not yet decided what that person will own.

A hybrid model works when ownership needs to stay close but specialist execution does not need to be permanent. One internal leader owns the growth thesis, budget, data access, approval path, and relationship between marketing and care delivery. The external team gets a defined remit, decision rights, response times, and success measures. That boundary matters more in healthcare, where clinical accuracy, patient privacy, platform policy, and advertising claims can collide inside one landing-page edit.

Compare cost structures honestly. Put the fully loaded internal team, including management and tools, beside the agency fee, internal coordination time, and any work still purchased separately. Then compare what each model can actually own. A cheaper structure that leaves the real bottleneck untouched is not cheaper.

Start with the 2026 cost floor, not a retainer sticker price

A salary is not the cost of an in-house team, and a retainer is not the cost of an agency relationship. Use public labor data to establish a floor, then replace it with your location, seniority, benefits, recruiting, software, contractor, and management assumptions.

That BLS occupational profile reports the $161,030 median annual wage for marketing managers in May 2024. It projects 6% growth for advertising, promotions, and marketing managers from 2024 to 2034 and about 36,400 openings per year across that group. These are national occupation figures, not telehealth quotes, but they expose the fiction that one senior internal hire is simply a monthly salary divided by twelve.

The March 2026 BLS Employer Costs for Employee Compensation data puts average total compensation for private-industry workers at $46.60 per hour. Within that, BLS reports $32.60 per hour for wages and salaries and $14.01 for benefits, so benefits run roughly 30% on top of wages. The category spans all of private industry, so it is a cost-structure anchor, not a budget recommendation for a healthcare startup.

Payroll adds another visible layer. The IRS 2026 Employer's Tax Guide sets the employer Social Security rate at 6.2% up to a $184,500 wage base and the employer Medicare rate at 1.45% with no wage-base limit. That is 7.65% in employer payroll tax on wages below the Social Security cap before state payroll taxes, workers' compensation, recruiting, equipment, or management time.

An agency comparison needs the same discipline. Add the fee, internal owner time, extra production vendors, tracking or creative tools outside scope, and transition costs. Then compare equal capability. A fractional team with paid media, creative, analytics, and conversion skills is not equivalent to one employee; one employee with deep company context is not equivalent to a rotating vendor bench.

Score the decision before you interview anyone

This is strategic guidance, not legal advice; claims, privacy, professional-licensing, and state-specific questions need qualified review.

  1. Name the bottleneck. Write one sentence: “Growth is constrained because we cannot ___.” If the blank is a specialized capability with a defined finish line, lean agency. If it is continuous cross-functional ownership, lean in-house. If it needs both, lean hybrid.

  2. Test repeatability. Can the team describe the audience, offer, patient journey, approval process, and business model without changing the answer every week? An agency can accelerate a working system or help diagnose one; it cannot manufacture operational consistency through campaign settings. If you do not know whether the constraint is message, media, intake, measurement, or retention, diagnose that before choosing a team structure.

  3. Decide how much speed is worth. An agency can provide existing specialists without a full recruiting cycle. In-house hiring may take longer, but the capability and learning remain inside the company. Define what must move now and what deserves permanent ownership before choosing.

  4. Separate senior judgment from production volume. Do you need an experienced person to make a few consequential calls, or a team producing and optimizing work every day? Do not hire a senior employee for a production queue or pay a senior agency team to wait for basic internal decisions.

  5. Assign one internal owner. Name the person who can approve priorities, access data, resolve conflicts, and say no. If that person does not exist, neither model will work cleanly. Expose missing ownership before it becomes an expensive communication problem.

  6. Keep clinical and privacy decisions close. Marketing can propose language and tests. Your clinical, privacy, and qualified legal reviewers must define the boundaries, approve the process, and retain escalation authority. Outsourcing execution does not outsource accountability.

The 2026 state AI rules make that division concrete. Texas HB 149 took effect January 1, 2026 and requires a provider using an AI system in relation to healthcare services to make the specified disclosure no later than the date the service is first provided, with an emergency exception. The law sets a civil-penalty range of $80,000 to $200,000 for each violation a court determines is uncurable. An agency can draft disclosure copy or configure a chatbot. The telehealth company still needs an internal owner who knows where the tool appears, which state rules apply, who approves the language, and how the deployment is documented.

  1. Compare the complete cost structure. For in-house, include recruiting, compensation, benefits, management, tools, contractors, and coverage gaps. For an agency, include fees, internal coordination, additional vendors, transition costs, and the work explicitly excluded from scope. Compare the same capability and ownership level on both sides.

  2. Choose where learning should compound. Patient insight, approved claims logic, funnel economics, and campaign history need a durable home. If you hire an agency, require documentation and accessible accounts. If you build in-house, make sure one employee's departure cannot erase the operating system.

The pattern matters more than a total score. As a heuristic, specialized gap + urgency + strong internal owner points toward an agency; stable workload + repeatable playbook + capable manager points in-house; mixed needs or a company between those states points toward a hybrid with explicit handoffs.

The thing an outside agency almost never asks about

From Pranay Parikh, MD:

Ask an agency what the most important part of a telehealth intake is and they will say the questions that qualify someone. It is not. It is the questions that disqualify someone, and it is what happens in the sixty seconds after.

When you tell a patient they are not a candidate, it is usually not because they are too healthy. It is because they are too sick. Sometimes it is because something in their answers suggests they are in real danger. A growth team looks at a disqualification screen and sees a drop-off to minimize. On the other side of that screen is a person who just told you something serious and is now being shown a door.

You cannot only tell them no. They need somewhere to go. Sometimes they need someone to reach out. That pathway has to exist before the first ad runs, and it has to be owned by someone accountable for it clinically, not by whoever is optimizing the funnel.

That is the first thing I check, and it is the thing an outside agency almost never asks about. Not because they are careless. Because it does not occur to them that the exit is the highest-stakes moment in the flow.

This is the real test of the build-versus-buy question. Not whether a partner can lower cost per lead. Whether anyone in the room knows what the intake is doing to the people it turns away.

Make the decision against your actual bottleneck

Bring the sentence from criterion one, your current funnel, and the ownership gaps you found. Book the 15-Min Healthcare Growth Fit Call to assess whether the next move is an agency, an internal hire, or a deliberately split hybrid, and whether Off-Label is the right fit for the external part.

The proof standard behind that conversation is in what to settle before you hire an agency: scope, access, approvals, and reporting.

Frequently asked questions

Is an agency cheaper than an in-house marketing team?

Not inherently. Compare the agency fee and internal coordination time with the fully loaded cost of recruiting, compensation, benefits, management, software, contractors, and specialist gaps. The useful comparison is equal capability and ownership, not retainer versus salary.

When is a telehealth company ready to hire a growth agency?

Readiness usually means the company can explain its offer, audience, economics, patient journey, claims-approval path, and measurement limits, and can name one internal decision-maker. If those pieces are unsettled, narrow the agency's first assignment to diagnosis rather than pretending the company is ready to scale execution.

What should never be fully outsourced?

Keep ownership of the growth thesis, budget, clinical truth, privacy decisions, data access, final approvals, and patient experience inside the company. Specialists can advise and execute, but the organization delivering care must retain the consequential decisions.

Can one in-house marketer replace an agency?

Sometimes, when the workload is stable and the role matches that person's strengths. One hire is less likely to replace senior strategy, channel execution, creative, conversion, analytics, and healthcare review at the same depth, so define the actual job before comparing models.

What does a hybrid healthcare marketing team look like?

A practical hybrid has one accountable internal owner and an external team with a narrow remit, clear decision rights, access rules, deliverables, and handoffs. The internal owner connects marketing to clinical, product, finance, and operations; the outside team supplies the specialist capability the company does not need to own full-time yet.

When should we revisit the decision?

Revisit it when the bottleneck, workload, growth model, management capacity, or risk profile changes materially. A team design that fits an experimental phase may become expensive friction once the work is repeatable, and an internal team can need outside depth when a new channel or capability becomes important.